Early Phase 1 Sleep Disorders Trial, Recruiting NCT05701969 Sponsor: University of Virginia Condition: Sleep Disorders
Back to Sleep Disorders

Early Phase 1 Sleep Disorders Trial, Recruiting

NCT05701969
Recruiting Early Phase 1

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are in their first through fifth year after completing medical school (Post-Graduate Year 1–5)
  • People currently enrolled in a residency program in anesthesiology, general surgery, obstetrics and gynecology, general medicine, or pediatrics at the University of Virginia

Who may not be able to join:

  • People who currently use sleep aids or medications to help with sleep
  • People who have been diagnosed with a sleep disorder
  • People who have a history of a pacemaker or other implanted medical device
  • Females who are pregnant or breastfeeding
  • People who have a bleeding disorder
  • People who have depression
  • People who have high blood pressure
  • People who have a seizure disorder
  • People who have had a transplant and are currently taking immunosuppression therapy (medications to prevent organ rejection)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.

Contact this trial

Principal Investigator: Lauren Dunn, MD PHD, University of Virginia

Phone: 9195931174

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Early Phase 1
Registry
ClinicalTrials.gov
Start date
30 May 2022
Est. completion
30 June 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Total Sleep Time (TST)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov